+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Skin Cancer Drugs Market Research Reports

From
From
From
From
From
From
From
From
From
From
Vismodegib (CAS 879085-55-9) Global Market Research Report 2024 - Product Thumbnail Image

Vismodegib (CAS 879085-55-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Sorafenib (CAS 284461-73-0) Global Market Research Report 2024 - Product Thumbnail Image

Sorafenib (CAS 284461-73-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Pemetrexed (CAS 137281-23-3) Global Market Research Report 2024 - Product Thumbnail Image

Pemetrexed (CAS 137281-23-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Amifostine (CAS 20537-88-6) Global Market Research Report 2024 - Product Thumbnail Image

Amifostine (CAS 20537-88-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Docetaxel (CAS 114977-28-5) Global Market Research Report 2024 - Product Thumbnail Image

Docetaxel (CAS 114977-28-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Dasatinib (CAS 302962-49-8) Global Market Research Report 2024 - Product Thumbnail Image

Dasatinib (CAS 302962-49-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Cilengitide (CAS 188968-51-6) Global Market Research Report 2024 - Product Thumbnail Image

Cilengitide (CAS 188968-51-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Carboplatin (CAS 41575-94-4) Global Market Research Report 2024 - Product Thumbnail Image

Carboplatin (CAS 41575-94-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Loading Indicator

The Skin Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat skin cancer. These drugs are used to treat a variety of skin cancer types, including melanoma, basal cell carcinoma, and squamous cell carcinoma. The drugs are typically administered orally, intravenously, or topically. The market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Novartis, Pfizer, and Roche. These companies are constantly researching and developing new treatments to improve the efficacy of existing treatments and to develop new treatments for skin cancer. In addition to the major players, there are also many smaller companies that are developing treatments for skin cancer. These companies are often focused on developing treatments for rarer forms of skin cancer, such as Merkel cell carcinoma. Examples of these companies include Aduro Biotech, Arcutis Biotherapeutics, and OncoSec Medical. Show Less Read more